These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3543425)

  • 1. Diabetogenic effect of pentamidine.
    Yurdakök M
    JAMA; 1987 Mar; 257(9):1177. PubMed ID: 3543425
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentamidine, a new diabetogenic drug in laboratory rodents.
    Saï P; Boillot D; Boitard C; Debray-Sachs M; Reach G; Assan R
    Diabetologia; 1983 Nov; 25(5):418-23. PubMed ID: 6360780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentamidine-induced free radical toxicity to isolated islet cells.
    Johansson AM; Grankvist KG
    AIDS; 1996 Jun; 10(6):684-5. PubMed ID: 8780829
    [No Abstract]   [Full Text] [Related]  

  • 4. Pentamidine isethionate-induced neutrophil dysfunction.
    Arnott MA; Hay T; Croft SL
    Ann Trop Med Parasitol; 1988 Dec; 82(6):627-9. PubMed ID: 3076751
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentamidine-induced pancreatic beta-cell dysfunction.
    Shen M; Orwoll ES; Conte JE; Prince MJ
    Am J Med; 1989 Jun; 86(6 Pt 1):726-8. PubMed ID: 2658578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigation of diabetogenic action of xanthurenic acid].
    Meíramov GG; Andreeva AP; Konert KD
    Biull Eksp Biol Med; 1997 Jun; 123(6):669-72. PubMed ID: 9280523
    [No Abstract]   [Full Text] [Related]  

  • 7. Pentamidine and hypoglycemia.
    Ganda OP
    Ann Intern Med; 1984 Mar; 100(3):464. PubMed ID: 6364914
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetogenic activity of xanturenic acid determined by its chelating properties?
    Meyramov G; Korchin V; Kocheryzkina N
    Transplant Proc; 1998 Sep; 30(6):2682-4. PubMed ID: 9745547
    [No Abstract]   [Full Text] [Related]  

  • 9. [The dynamics of the Zn content in the pancreatic islets of rabbits after the administration of the diabetogenic agent dithizone].
    Gol'dberg ED; Eshchenko VA; Bovt VD
    Patol Fiziol Eksp Ter; 1991; (4):43-5. PubMed ID: 1798653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of diabetogenic substances on the zinc and calcium content in the pancreatic islet cells of rabbits].
    Gol'dberg ED; Eshchenko VA; Bovt VD
    Biull Eksp Biol Med; 1991 Feb; 111(2):135-7. PubMed ID: 1854952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Zinc content in pancreatic islets in experimental diabetes induced by chelating agents].
    Bavel'skiĭ ZE; Zaviazkina TV; Moiseev IuS; Medvedev VI
    Patol Fiziol Eksp Ter; 1992; (3):29-32. PubMed ID: 1480418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protection of the islet apparatus in experimental alloxan diabetes].
    Kudriashov BA; Pytel' IuA; Baskakova GM; Sokolova GA; Liapina LA
    Patol Fiziol Eksp Ter; 1982; (2):67-70. PubMed ID: 7045785
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of alloxan-like compounds derived from uric acid.
    Ashcroft SJ; Harrison DE; Poje M; Rocic B
    Br J Pharmacol; 1986 Nov; 89(3):469-72. PubMed ID: 3542106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A enhances streptozocin-induced diabetes in CD-1 mice.
    Iwakiri R; Nagafuchi S; Kounoue E; Nakano S; Koga T; Nakayama M; Nakamura M; Niho Y
    Experientia; 1987 Mar; 43(3):324-7. PubMed ID: 2951271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-cell toxins on genetically engineered insulin-secreting cells.
    Tuch BE; Beynon S; Tabiin MT; Sassoon R; Goodman RJ; Simpson AM
    J Autoimmun; 1997 Jun; 10(3):239-44. PubMed ID: 9218749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.
    Eldor R; Yeffet A; Baum K; Doviner V; Amar D; Ben-Neriah Y; Christofori G; Peled A; Carel JC; Boitard C; Klein T; Serup P; Eizirik DL; Melloul D
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5072-7. PubMed ID: 16551748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical elimination of the alpha cells of islands of Langerhans.
    VON HOLT C; VON HOLT L; KRONER B; KUHNAU J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1955; 224(1):66-77. PubMed ID: 13235907
    [No Abstract]   [Full Text] [Related]  

  • 19. New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells.
    Kawada J; Toide K; Nishida M; Yoshimura Y; Tsujihara K
    Diabetes; 1986 Jan; 35(1):74-7. PubMed ID: 2934286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic aspects of pentamidine.
    Waalkes TP; Makulu DR
    Natl Cancer Inst Monogr; 1976 Oct; 43():171-7. PubMed ID: 1018718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.